HomeFat BurnersSUP3R-SHRED

SUP3R-SHRED

$53.99

Subscribe for this Product
Categories: , .

Description

SUP3R-SHRED

Introducing SUP3R-SHRED, where science and shredding meet!

We at Olympus UK are proud to present a compound never before brought to market! A leap forward in innovation, Alpha tested in house for safety and efficacy, we bring you… SUP3R-SHRED!

So, what is the active ingredient in SUP3R-SHRED that makes it innovative? Well, SUP3R-SHRED contains Dibromo-4-methoxybiphenyl, a naturally occurring molecule derived from the herb Artemisia Iwayomogi (of the Asteraceae family), commonly referred to as “Haninjin,”[1] one of the major medicinal materials used in traditional Korean medicine, which can  also can be found in Korean cuisine.

Data regarding a 95% ethanolic extract of Artemisia Iwayomogi, which contained 3.55% Dibromo-4-methoxybiphenyl, showed the ability to activate PPAR-Delta (peroxisome proliferator-activated receptor delta), a mechanism that is unique among supplements.[2] This same extract was shown to increase skeletal muscle fatty acid oxidation and increase the expression of genes involved in lipid catabolism, as well as attenuate body weight gain in high fat diet-fed mice and thus protect against diet-induced obesity. It is plausible that Dibromo-4-methoxybiphenyl alone is directly responsible for this effect, as it does share a weak structural similarity to GW501516 (Cardarine), a synthetic PPAR-Delta agonist noted for similar effects. However, unlike GW501516, Dibromo-4-methoxybiphenyl is a naturally occurring molecule with a long-standing safety record as a component of Haninjin, which has been consumed in Korea for generations as part of traditional Korean medicine. This makes Dibromo-4-methoxybiphenyl the safest and strongest PPAR-Delta agonist on the market!

So what is PPAR-delta, and what does agonism (activation) of this receptor do? Simply put, PPAR-Delta is a regulator of lipid metabolism, and agonism of this receptor has been shown to induce fatty acid oxidation via PGC-1alpha.[3] In fact, it changes the body’s fuel preference from glucose to lipids. Brunmair et al. reported that PPAR-Delta activation acts to suppress glucose utilization as a result of a switch in substrate preference from carbohydrates to lipids in skeletal muscle. [5] That translates to enhanced body fat loss and improved endurance capabilities. And may even potentially lead to enhanced recovery, as PPAR-Delta activation is also associated with enhanced skeletal muscle regeneration.[4] PPAR-Delta activators even have positive general health effects, such as being shown to improve insulin resistance, reduce plasma glucose and reduce serum triglycerides.

So, in summary:

-Aids in Body Fat Reduction

-Increases Stamina

-Increases Endurance

-Enhances Athletic Performance

-Enhances Skeletal Muscle Regeneration

-Improves Insulin Resistance

-Potentially Reduces Serum Triglycerides

Don’t pass up on the benefits of Dibromo-4-methoxybiphenyl and its game-changing PPAR-Delta modulating abilities! In typical Olympus UK fashion, we cut no corners, with SUP3R-SHRED containing a mind-blowing 9g of Dibromo-4-methoxybiphenyl per bottle! That’s a full 30-day supply of 300mg per day! Get on the cutting edge of getting cut, see where science meets shredding, and pick up your bottle of SUP3R-SHRED today!

~Side Effects of SUP3R-SHRED:

In-house Alpha testing showed no side effects whatsoever, nor are there any known side effects associated with Artemisia Iwayomogi extracts. SUP3R-SHRED is a non-hormonal, and thus a non-suppressive, product. It requires no PCT following usage.

~Dosing, Timing and Cycle Length:

The recommended dosing for SUP3R-SHRED is 3 capsules (300mg) daily, with 1 capsule (100mg) taken 3 times per day before meals. Optimal cycle lengths are 30-60 days.

~SUP3R-SHRED Example Cycles & Stacking Guidelines:

There are near limitless cycles that SUP3R-SHRED can be stacked with, here are just a few examples to better illustrate the versatility of the compound. Note: These are just simple examples, and cycles can be ran longer than 4 weeks, dosed at different times, and stacked with other compounds.

*Beginner – Cutting Cycle: (30 Day Cycle, Over 4 Weeks)

-SUP3R-SHRED ——- 300/300/300/300 (1 bottle Olympus UK SUP3R-SHRED – 90 Caps)

-IGNIT3 —————– 5/5/5/5 [Caps per day] (1 bottle Olympus Labs IGNIT3 – 150 Caps)

*Advanced – Cutting Cycle: (30 Day Cycle, Over 4 Weeks)

-SUP3R-SHRED ——– 300/300/300/300 (1 bottle Olympus UK SUP3R-SHRED – 90 Caps)

-SUP3-EPI ————— 1000/1000/1000/1000 (1 bottle Olympus UK SUP3R-EPI ELITE – 120 Caps)

-IGNIT3 —————— 5/5/5/5 [Caps per day] (1 bottle Olympus Labs IGNIT3 – 150 Caps)

*Experienced – Cutting Cycle: (30 Day Cycle, Over 4 Weeks)

-SUP3R-SHRED ——– 300/300/300/300 (1 bottle Olympus UK SUP3R-SHRED – 90 Caps)

-SUP3-EPI ————— 1000/1000/1000/1000 (1 bottle Olympus UK SUP3R-EPI ELITE – 120 Caps)

-IGNIT3 —————— 5/5/5/5 [Caps per day] (1 bottle Olympus Labs IGNIT3 – 150 Caps)

*Post Cycle Therapy (PCT): (30 Days, Over 4 Weeks)

-Olympus Labs SUP3R PCT (As indicated on label)

{Only required if using the Advanced or Experienced Cutting Cycles containing SUP3R-EPI)

References:

[1]  Doh EJ, Oh SE Multiplex PCR method to discriminate Artemisia iwayomogi from other Artemisia plants . Methods Mol Biol. (2012)

[2] Cho SY, et al An ethanol extract of Artemisia iwayomogi activates PPARd leading to activation of fatty acid oxidation in skeletal muscle . PLoS One. (2012)

[3] Kleiner S1, Nguyen-Tran V, Baré O, Huang X, Spiegelman B, Wu Z. PPAR{delta} agonism activates fatty acid oxidation via PGC-1{alpha} but does not increase mitochondrial gene expression and function. J Biol Chem. 2009 Jul 10;284(28):18624-33. doi: 10.1074/jbc.M109.008797. Epub 2009 May 12.

[4] Embler, Emi Kanakubo, Ph.D., PPARdelta activation enhances skeletal muscle regeneration UNIVERSITY OF CALIFORNIA, SAN DIEGO, 2012, 93 pages; 3494293

[5] Brunmair B, Staniek K, Dorig J, Szocs Z, Stadlbauer K, et al. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids. Diabetologia. 2006;49:2713–2722. [PubMed]

Disclaimer: While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Olympus UK assumes no liability for inaccuracies or misstatements about products.